; however, the exact interval was not specified.
concentration even when the blood is collected under the same conditions and the lipids are analyzed in the same laboratory (2). Lifestylefactors such as diet, exercise, change of body weight, drugs, and season contribute to the CVb, which accounts for a major part of the total variability (CVi) (3-7). CV arises from the lack of desired precision (reproducibility of measurements) and accuracy (deviation from true value) of the assay; its contribution to CV is potentially small (5) (6) (7) . Although the CVb of TC has been recognized since 1928 (8), many dietary and epidemiological studies have not taken this into account and stifi rely on a single blood sample for estimating subjects' average concentrations of TC and LP. In some population screening programs, people have been classified as moderateor high-risk individuals on the basis of a single cholesterol determination (9) ; investigators in the Whitehall study used a single measure for TC determination (10) ; TC, total cholesterol; LP, lipoprotein; HDL-C, high-density lipoprotein cholesterol; CVb, biological variation; CV,,, analytical variation; and CVI, total variability.
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and, in some intervention studies, the efficacy of treatment by lipid-lowering drugs or diet has been tested by comparison with only one pretreatment value (11, 12) . Genetic studies on the association between plasma lipids or LPs and coronary heart disease have also frequently been based on a single determination of lipids (13) (14) (15) .
Repeated blood sampling is advocated to improve the reliability of an estimate for TC or LP concentration One subject did not complete the study, and another subject, as seen from her hormone profile, did not ovulate (48). Data from the remaining 13 subjects were used for statistical analysis.
Experimental Design
Subjects were participating in a prospective study on variations in plasma amino acids, LPs, and reported food intake during the menstrual cycle. The study extended over 5 weeks, during which time fasting blood samples were taken every Monday, Wednesday,
Friday,
and Saturday between 0730 and 0900, giving a total of 20 blood samples per subject. The subjects remained seated for at least 15 mm before blood was taken by a qualified nurse, who used several different sites in the arm to allow healing of veins between withdrawal of samples. An interviewwas conducted to determine food and drink consumed the previous evening, and to check compliance with overnight fasting. Subjects traveled to the study site by various means, including walking, cycling, and driving by car, motorbike, or bus. Subjects were asked to use the same means of transport each morning; otherwise, no restriction was placed on morning exercise. Dates of menstruation were obtained during and at the end of the study period, and subjects were weighed weekly. This protocol had the approval of University of Sydney Medical Ethics Review Committee and all subjects gave their informed written consent.
AnalyticalMethods
Blood samples were collected into tubes containing EDTA or lithium heparin and centrifuged immediately (1200g, 15 mm) to minimize osmotic shifts between erythrocytes and plasma (4, 5). Plasma was stored at -80#{176}C until analysis.
Because of the short supply of EDTA plasma for two subjects, respective aliquots of EDTA and heparin plasma were pooled for the lipoprotein analyses in these subjects (48 CVs for TC and HDL-C, estimated from control samples run in each assay, were 2.7% (n = 24) and 3.0% (n = 22), respectively.
Withinassay CVs for TC and HDL-C were 1.8% (n = 18) and 1.5% (n = 20), respectively.
StatisticalAnalysis
The mean CV for TC and HDL-C (n = 13) was calculated, and, using the estimated values for CV and between-assay CVa, we calculated CVb according to the following formula (46): HDL-C 80 30 n = 13 each. cv,, was estimated from control samples run in each assay; CVb was calculated according to the formula (a): Ve,licaJ bars represent the SEM. Days between sampling
Fig.2. Smoothed CVsofsemivariograms for TC (A) andHDL-C(B)
as a function oftime between repeat blood measurements.
obtained by taking repeat blood samples -2 weeks apart.
To our knowledge, only two studies have examined the within-person variability in TC and HDL-C as a function of the sampling time interval. In the first of these, Harris (52) collected data from 29 male students and calculated the variance of the differences in TC between successive observations at intervals of 1, 7, and 30 days. He exssmined only these three intervals and did not calculate semivariograms.
There was a linear increase in variance from the 1-day to the 30-day interval. 3, 4, 7, 10, 11, and 14 days. These authors found an increase in variability as the interval increased from 0 (simultaneous duplicates) to 4 days; they also noted a small, nonsignificant second increase between the 10-and 14-day intervals.
The maximum variabifity of -5% reported by Rotterdam et al. (45) for intervals of 10 to 14 days was lessthan the corresponding value of -10% we observed in our study. Different lifestyle conditions might explain the discrepancy in the two data sets; subjects in their study were participating in metabolic experiments in which diet was strictly controlled, whereas our subjects were free-living.
Concentrations of lipids and lipoproteins can undergo fluctuations with the menstrual cycle. In our previous analysis (48) of the current data, we reported that the maximum increase in TC and HDL-C occurred between the time of menstruation and ovulation, -14 days apart. Compared with TC, the increase in HDL-C at ovulation was more prolonged and the concentrations remained increased until the following premenstrual phase. These hormonally determined changes would be expected to exert a significant effect on the current analysis and could be reflected in the maximum variability we observed at sampling intervals of -2 weeks. Furthermore, because calculation of the semivariogram for a particular interval includes all possible combinations of sample pairs, a 2-week interval would be expected to maximize the within-subject variation Our data for within-person variability represents both CVb and (Na (we did not separate these components). Possible sources of CVb include changes in diet or lifestyle factors such as alcohol consumption and exercise, but also fluctuations in ovarian hormones (4) (5) (6) 48) . In the longer term, seasonal changes could also exert an effect, although our 5-week study was too short for these to be an important influence. With regard to CVb, our subjects were representative of the normal population of menstruating women: They were free-living, not following any special dietary regimen, and, as confirmed by hormonal measurements (48), had typical ovulatory cycles with a mean (range) cycle length of 29 (23-33) days. Therefore, the variability in blood lipid concentrations we observed is probably typical of the normal variabffity in this group. CVa can contribute significantly to the CVI, particularly in the measurement of HDL-C, where the analysis involves a precipitation procedure (43, 46, 53-55). In view of this potential source of error, some authors have suggested that a single estimate of HDL-C measured in an individual may not be useful in the primary assessment of risk for heart disease (54). However, even after accounting for factors known to affect plasma TC and HDL-C concentrations, a considerable proportion of the variability for TC and HDL-C remains unexplained (3). Characterization of the usual variationsin plasma TC and HDL-C, as conducted in this study, will enable the use of duplicate blood samples to come nearer to reflecting a subject's true mean values.
We believe this study is the first to examine the within-subjectvariability in blood samples from young women over a 5-week period. In our previous analysis of the current data examining fluctuations of TC and HDL-C during the menstrual cycle, we observed peaks and troughs occurring -2 weeks apart (48). By applying time-series analysis of variability to these same data (reported here), we also find the maximum difference at -2-week intervals.
Given the mutual support of these two sets of results, we propose that the best estimates of the true mean for concentrations of plasma cholesterol and HDL-C in young women can be obtained by taking samples 2 weeks apart.
